2 years ago
PFE
AnalystsColin BristowColin Bristow's Stock Forecasts
AnalystsColin Bristow
Sectors:
Industries:
Analyst Ranking
Bottom 5%
#4720 out of 4928 analysts
Average Return
-13.29%
Win Rate
32%18 out of 56
Risk vs Reward
Poor
Good
Colin Bristow's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Molecular Templates IncMTEM | +136.78% | $107.25 | $253.95 | 2019-04-28 - 2020-04-29 | Strong Buy |
Alx Oncology Holdings IncALXO | +114.84% | $5.19 | $11.15 | 2023-03-14 - 2024-03-14 | Strong Buy |
Bioxcel Therapeutics IncBTAI | +76.69% | $295.84 | $522.72 | 2022-02-15 - 2023-02-15 | Strong Buy |
Eli Lilly & CoLLY | +59.35% | $360.01 | $573.67 | 2022-12-14 - 2023-12-14 | Strong Buy |
Rocket Pharmaceuticals IncRCKT | +52.60% | $13.48 | $20.57 | 2022-09-26 - 2023-09-26 | Strong Buy |
Colin Bristow Analyst Color
Get additional color on Colin Bristow's coverage of popular stocks
2 years ago
PFE
3 years ago
MRK
3 years ago
ABBV
4 years ago
MRK
4 years ago
PFE
Colin Bristow's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Rocket Pharmaceuticals IncRCKT | 3 | Strong Buy | $5.00 | +77.94% | Maintains | 21 days ago |
Alx Oncology Holdings IncALXO | 6 | Strong Buy | $1.00 | +125.23% | Maintains | 2 months ago |
Immunovant IncIMVT | 6 | Hold | $17.00 | +3.53% | Downgrades | 3 months ago |
Amgen IncAMGN | 8 | Hold | $319.00 | +8.89% | Maintains | 3 months ago |
Acumen Pharmaceuticals IncABOS | 4 | Strong Buy | $4.00 | +244.83% | Maintains | 3 months ago |
Engene Holdings IncENGN | 2 | Hold | $7.00 | +83.73% | Downgrades | 5 months ago |
Vertex Pharmaceuticals IncVRTX | 14 | Strong Buy | $583.00 | +26.90% | Maintains | 5 months ago |
Pfizer IncPFE | 10 | Hold | $28.00 | +10.94% | Maintains | 5 months ago |
Merck & Co IncMRK | 6 | Strong Buy | $120.00 | +48.33% | Maintains | 6 months ago |
Ptc Therapeutics IncPTCT | 3 | Strong Buy | $71.00 | +47.98% | Maintains | 7 months ago |
Gilead Sciences IncGILD | 3 | Hold | $96.00 | -14.12% | Maintains | 8 months ago |
Biogen IncBIIB | 10 | Hold | $202.00 | +55.23% | Maintains | 9 months ago |
Bioxcel Therapeutics IncBTAI | 5 | Hold | $16.00 | +742.11% | Maintains | a year ago |
Regeneron Pharmaceuticals IncREGN | 1 | Strong Buy | $1,099.00 | N/A | Maintains | a year ago |
Sarepta Therapeutics IncSRPT | 4 | Strong Buy | $167.00 | N/A | Maintains | a year ago |
Eli Lilly & CoLLY | 1 | Strong Buy | $420.00 | N/A | Maintains | 3 years ago |
Omeros CorpOMER | 2 | Hold | $2.00 | N/A | Downgrades | 3 years ago |
Prokidney CorpPROK | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 3 years ago |
Abbvie IncABBV | 2 | Hold | $146.00 | N/A | Maintains | 3 years ago |
Bristol Myers Squibb CoBMY | 1 | Hold | $75.00 | N/A | Maintains | 3 years ago |
C4 Therapeutics IncCCCC | 1 | Strong Buy | $26.00 | N/A | Maintains | 3 years ago |
Candel Therapeutics IncCADL | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | 4 years ago |
Molecular Templates IncMTEM | 2 | Hold | $195.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.